Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bellerophon Therapeutics Inc BLPH

Healthcare Biotechnology
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company’s focus is to develop its nitric oxide therapy for patients with pulmonary hypertension (PH) using its delivery system, INOpulse. The Company’s INOpulse program is an... see more

Recent & Breaking News (GREY:BLPH)

Bellerophon Announces First Patient Enrolled in Phase 2b Study Evaluating INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

GlobeNewswire January 3, 2018

Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors

GlobeNewswire November 30, 2017

Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results

GlobeNewswire November 7, 2017

Bellerophon Announces $23 Million Private Placement

GlobeNewswire September 27, 2017

Bellerophon Therapeutics to Provide Corporate Update at Two Investor Conferences

GlobeNewswire September 7, 2017

Bellerophon Announces Positive Top Line Phase 2 Data of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

GlobeNewswire September 5, 2017

Bellerophon Reports Second Quarter 2017 Financial Results and Provides Business Update

GlobeNewswire August 7, 2017

Bellerophon Announces FDA Agreement on Phase 2b Study Design for INOpulse® in Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

GlobeNewswire August 3, 2017

Biotech Stock Performance Review -- Alder Biopharma, Ardelyx, Bellerophon Therapeutics, and Corbus Pharma

PR Newswire June 26, 2017

Biotech Stocks Under Scanner -- Juno Therapeutics, Nektar Therapeutics, Threshold Pharma, and Bellerophon Therapeutics

PR Newswire May 25, 2017

Positive Clinical Data on INOpulse® Presented at the American Thoracic Society 113th International Conference

GlobeNewswire May 22, 2017

Bellerophon Reports First Quarter 2017 Financial Results and Provides Business Update

GlobeNewswire May 15, 2017

Bellerophon Announces $3.0 Million Registered Direct Offering

GlobeNewswire May 10, 2017

Bellerophon to Present Positive Clinical Data on INOpulse® at the American Thoracic Society 113th International Conference

GlobeNewswire May 1, 2017

18 Biggest Mid-Day Losers For Friday

Benzinga.com  April 7, 2017

Mid-Day Market Update: Gold Futures Up Over 1%; DryShips Shares Plunge

Benzinga.com  April 7, 2017

Mid-Morning Market Update: Markets Edge Lower; U.S. Economy Adds 98,000 Jobs In March

Benzinga.com  April 7, 2017

18 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  April 7, 2017

Clinical Data on INOpulse® Presented at 37th Annual Meeting for the International Society for Heart and Lung Transplantation (ISHLT)

GlobeNewswire April 7, 2017

Bellerophon Announces Poster Presentation on INOpulse® at 37th Annual Meeting for the International Society for Heart and Lung Transplantation

GlobeNewswire March 27, 2017